CD40LG and cancer: The CD40-CD40L signaling pathway has been associated with the pathogenic processes of chronic inflammatory diseases, including autoimmune diseases, neurodegenerative disorders, graft-versus-host disease, cancer, vasculitis, and atherosclerosis [17, 20].